Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

GSK Promotes Open Innovation by Sharing Malaria Inhibitor Compounds

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By James DeGiulio -- Earlier this year, GlaxoSmithKline announced an "open innovation" strategy to help deliver new and better medicines for diseases disproportionately affecting people living in the world's poorest countries. Making good on that promise, GSK has teamed up with the European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM), and Collaborative Drug Discovery (CDD) to make freely available more than 13,500 compounds that could ultimately lead to new treatments for malaria. The data was generated by screening GSK's library of 2 million compounds for those that demonstrate potent inhibition of the most deadly malaria parasite, Plasmodium...

Full post as published by Patent Docs on May 27, 2010 (boomark / email).